Release Date: 2024-04-04

Newborn Screening for Biotinidase Deficiency

Release Date: 2024-04-04

Biotinidase deficiency is an inherited metabolic disorder with a very good prognosis if diagnosed and treated early. Cost-effectiveness has been demonstrated. therefore biotinidase deficiency is covered by newborn screening in many countries around the world. In countries like Turkey, where consanguineous marriages are common, morbidity and mortality have been prevented in a large number of [...]

Media Type
  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inNewborn and Childhood Screening Programmes
First Page65
Last Page79
DOIhttps://doi.org/10.69860/nobel.9786053358961.5
ISBN978-605-335-896-1 (PDF)
LanguageENG
Page Count15
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
Biotinidase deficiency is an inherited metabolic disorder with a very good prognosis if diagnosed and treated early. Cost-effectiveness has been demonstrated. therefore biotinidase deficiency is covered by newborn screening in many countries around the world. In countries like Turkey, where consanguineous marriages are common, morbidity and mortality have been prevented in a large number of individuals with early treatment through national screening programs. The prevalence of biotinidase deficiency varies from country to country and from region to region. Since false positivity and negativity may occur, the diagnosis should be confirmed by quantitative method and molecular genetic analysis.

Ilknur Surucu Kara (Author)
MD, Gaziantep City Hospita
https://orcid.org/0000-0001-7842-9278
3Nutrition and paediatric metabolism specialist, paediatric health and diseases specialist, medical doctor İlknur Sürücü Kara has been working in her profession for twenty years. She has more than forty publications, more than fifty oral presentations and posters, as well as participation in scientific social activities and a moderator. Her academic education is as follows: 2020-2023 Ankara University, Faculty of Medicine Department of Paediatric Metabolism. 2014-2020 Erzincan Binali Yıldırım University, Faculty of Medicine, Department of Pediatrics - head of the department. 2006 - 2010 Atatürk University Faculty of Medicine Department of Pediatrics. 1996-2002 Ege University Faculty of Medicine. The unit she is currently working in: Department of Pediatric Metabolism and Nutrition, Gaziantep City Hospital, Gaziantep, Turkey.

  • Akova, İ., Kılıç, E., & Koşaroğlu, N. E. (2022). Yenidoğan metabolik ve endokrin hastalıkların 10 yıllık tarama programı sonuçlarının değerlendirilmesi: Sivas ili, Türkiye örneği. Turkish Journal of Public Health, 20(3), 410-422

  • Bayrak, R., Ünsal, A., & Ünlü, E. (2023). Kırşehir İlinde 2015-2020 Yılları Arasında Neonatal Tarama Programı Sonuçlarının İncelenmesi. Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi, 6(2), 33-40.

  • Çoker, M. (2017). Screenings. In M. Yurdakök (Ed.), Yurdakök pediatrics (pp. 1567-1525). Güneş Medical Houses.

  • Heard, G. S., Secor McVoy, J. R., & Wolf, B. (1984). A screening method for biotinidase deficiency in newborns. Clin Chem, 30(1), 125-127

  • 10.1016/s0022-3476(86)80766-1

  • Henderson, M. P., McIntosh, N., Chambers, A., Desormeaux, E., Kowalski, M., Milburn, J., & Chakraborty, P. (2023). Biotinidase activity is affected by both seasonal temperature and filter collection cards. Clinical Biochemistry, 115, 129-136

  • 0. https://data.tuik.gov.tr/Search/Search?text=bebek%20say%C4%B1s%C4%B1&dil=1.

  • https://hsgm.saglik.gov.tr/depo/birimler/cocuk-ergen-sagligi-db/Dokumanlar/Egitim_Dokumanlari/ Saglik_Personeli/NTP_Saglik_Personeli.pdf

  • https://hsgm.saglik.gov.tr/depo/birimler/cocuk-ergen-sagligi-db/Dokumanlar/Istatistikler/NTP.pdf.

  • https://hsgm.saglik.gov.tr/tr/tarama-programlari/ntp.html.

  • https://www.ncbi.nlm.nih.gov/clinvar/?term=btd%5Bgene%5D&redir=gene.

  • . Karaca, M., & Kazanasmaz, H. (2019). Specificity and sensitivity of biotinidase activity measured from dried blood spot by colorimetric method. Annals of Medical Researc, 26.

  • Luz Gdos, S., Carvalho, M. D., Pelloso, S. M., & Higarashi, I. H. (2008). [Prevalence of diseases diagnosed by the Program of Neonatal Screening in Maringá, Paraná, Brazil: 2001-2006]. Rev Gaucha Enferm, 29(3), 446-453. (Prevalência das doenças diagnosticadas pelo Programa de Triagem Neonatal em Maringá, Paraná, Brasil: 2001-2006.)

  • Schweitzer, S., Sander, J., Suormala, T., Baumgartner, R., Byrd, D. J., & Brodehl, J. (1991). [Biotinidase deficiency. Results of neonatal screening 1985-1989 in Lower Saxony]. Monatsschr Kinderheilkd, 139(6), 349-354. (Der Biotinidasemangel. Ergebnisse des Neugeborenen-Screenings 1985-1989 in Niedersachsen.)

  • Strovel, E. T., Cowan, T. M., Scott, A. I., & Wolf, B. (2017). Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics. Genetics in Medicine, 19(10), 1079-1079.

  • Vallejo-Torres, L., Castilla, I., Couce, M. L., Pérez-Cerdá, C., Martín-Hernández, E., Pineda, M., . . . Serrano-Aguilar, P. (2015). Cost-effectiveness analysis of a national newborn screening program for biotinidase deficiency. Pediatrics, 136(2), e424-e432.

  • Wolf, B. (1993). Biotinidase Deficiency. In M. P. Adam, J. Feldman, G. M. Mirzaa, R. A. Pagon, S. E. Wallace, L. J. H. Bean, K. W. Gripp, & A. Amemiya (Eds.), GeneReviews(®). University of Washington, Seattle

  • Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

  • 0.1620/tjem.152.339

Share This Chapter!